Trial Condition(s):
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
To show efficacy of Zarzenda in the treatment of hand eczema
- Mild to moderate hand eczema for at least 3 months - At least 4 weeks have passed since use of systemic treatment for eczema - At least 4 weeks have passed since any vaccination - At least 1 week has passed since last topic treatment on hands with corticosteroids - Agree to use adequate contraceptive method if of childbearing potential - Willingness to avoid excessive exposure to sunlight and avoid skin irritants
- Pregnancy, breast feeding - Severe excoriations on the hands - Need for systemic treatment for atopic dermatitis - Known sensitivity to Zarzenda and/or to extract of nut butyrospermum parkii (shea) - Known immune deficiency - Concomitant infection on hands
Locations | Status | ||
---|---|---|---|
Locations Intendis GmbH Berlin, Germany | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema
Trial Type:
Interventional
Intervention Type:
Device
Trial Purpose:
Treatment
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1